scispace - formally typeset
Open Access

Федеральное государственное бюджетное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний» Сибирского отделения Российской академии медицинских наук, Кемерово, Россия

TLDR
The outcomes of CAD surgical treatment were improved in this group of patients due to the implementation of a mul-assisted revascularization of coronary and non-coronary arteries.
Abstract
Results. The incidence rate of significant non-cardiac occlusive stenotic lesions in patients with coronary artery disease (CAD), who had to undergo CABG, was 15,84 %. Simultaneous revascularization of coronary and non-coronary arteries was performed in 2,46 % of patients with CAD and PolyVD and multi-stage surgical proced ures were chosen in other cases. Conclusions. The outcomes of CAD surgical treatment were improved in this group of patients due to the implementation of a mul-

read more

Content maybe subject to copyright    Report

Citations
References
More filters
Journal ArticleDOI

Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel

TL;DR: A consensus meeting was convened to develop recommendations for standardizing the administration of Bendamustine based on the available clinical data, and recommendations were developed including dose and schedule for the various clinical indications, as a single agent and in combination therapy.
Journal ArticleDOI

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

TL;DR: The identification of citruLLinated vimentin as a prominent citrullinated antigen in IC from SF of ACPA+ RA patients strengthens the hypothesis that citruellinated vimentsin plays an important role in the pathogenesis of RA.
Journal ArticleDOI

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

TL;DR: It is demonstrated through simulation that genome-wide genotyping, coupled with the use of clinically matched or population controls, can yield sufficient statistical power to permit the identification of strong genetic predictors of ADR risk in a prospective manner with modest numbers ofADR cases.